Biểu đồ giá cổ phiếu MENS
MENS Dự đoán giá cổ phiếu
Jyong Biotech Ltd
$1.64
3.14%
$0.04
Khi đóng cửa: Jun 23, 16:00:00 GMT-4
$1.64
0%
$0
Phiên trước giờ: Jun 24, 05:29:53 GMT-4
Quay lại
Jyong Biotech Ltd (MENS) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$1.59
Giá mở cửa
$1.58
Phạm vi ngày
$1.58 - $1.67
Phạm vi 52 tuần
$1.43 - $67
Khối lượng
230.0K
Khối lượng trung bình
228.3K
Tỷ suất cổ tức
--
EPS (TTM)
-0.08
Vốn hóa thị trường
$124.6M
MENS là gì?
Jyong Biotech Ltd. operates as a holding company, which engages in the development of biotechnology products. The company is headquartered in Taipei City, New Taipei and currently employs 29 full-time employees. The company went IPO on 2025-06-17. The firm is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The firm has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.
